Loading…
Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes
Bone marrow mesenchymal stromal cells (BM-MSCs) with regenerative potential have been identified in heart. Whether these cells become new cardiac lineage cells by phenomena of transdifferentiation or fusion is also being investigated. Although, these mechanisms give cardiomyocytes, it has to be cons...
Saved in:
Published in: | Differentiation (London) 2010-02, Vol.79 (2), p.93-101 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3 |
---|---|
cites | cdi_FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3 |
container_end_page | 101 |
container_issue | 2 |
container_start_page | 93 |
container_title | Differentiation (London) |
container_volume | 79 |
creator | Labovsky, V. Hofer, E.L. Feldman, L. Fernández Vallone, V. García Rivello, H. Bayes-Genis, A. Hernando Insúa, A. Levin, M.J. Chasseing, N.A. |
description | Bone marrow mesenchymal stromal cells (BM-MSCs) with regenerative potential have been identified in heart. Whether these cells become new cardiac lineage cells by phenomena of transdifferentiation or fusion is also being investigated. Although, these mechanisms give cardiomyocytes, it has to be considered that MSCs transplantation could carry out ossification and calcification processes. An alternative might be the use of myocytes; however, the problem is the arrythmia. For those reasons, is that we investigated how to obtain cardiomyocyte-like cells from human MSCs (hMSCs). The aim of the present work was to evaluate a nuclear reprogramming of the hMSCs by a neonatal rat cardiomyocytes extract (EX) using Streptolysin O (SLO) treatment. hMSCs treated with 57.5
ng/ml SLO presented ball-like, stick-like and myotube-like morphology. In the absence of cardiomyogenic stimuli, hMSCs expressed markers of cardiac phenotype-like sarcomeric α-actinin, connexin-43 and GATA-4. However, when hMSCs were treated with SLO+EX or 10
μM of 5-azacytidine (5-AZA), the expression of these markers were significantly increased and furthermore, expressed SERCA-2, cardiac Troponin I, β-MyHC, desmin, MLC-2a and MLC-2v thus showing the phenotype of mature cardiomyocytes. PCR analysis showed that cardiomyocyte-related genes, such as β1-adrenergic receptor (β1-AR), MLC-2a and cardiac Troponin T, were expressed after SLO+EX treatment like with 5-AZA. We concluded that the extract of neonatal rat cardiomyocytes could promote a nuclear modification of hMSCs to cardiomyogenic-like cells differentiation. Since the 5-AZA treatment appears to be genotoxic and taking into account the obtained results, the nuclear reprogramming by cell extract may be an approach leading to the identification of soluble factors that drives the reprogramming. |
doi_str_mv | 10.1016/j.diff.2009.10.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745933973</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301468109001133</els_id><sourcerecordid>745933973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3</originalsourceid><addsrcrecordid>eNqFkU2LFDEQhoO4uOPqH_AguXnqsarTne6IFxn8goWFZT2HJF3tZujurEnGdU7-ddPMgDc9BYqnnhTvy9grhC0Cyrf77eDHcVsDqDLYAuATtsFG1BU0Qj5lGxCAVSN7vGTPU9oDQC9rfMYuUalaCiU27PfOxMGH-Ri-0-IdX40UacneZB8WHkZ-f5jNwm1YiM8mxvDIZ0q0uPvjbCbuaJrSO34bJlpht-qM4_QrR-MyH2OY-UJhMbnA0eQTsX7ojpnSC3YxminRy_N7xb59-ni3-1Jd33z-uvtwXblGYK5aMJJwwK4fWrIkB1AOrXWyaaRVxgrT4ShkD21fq9bZfhRIvbHQIgIMVlyxNyfvQww_DpSynn1abzfluEPSXdMqIVQn_k8KITrosC9kfSJdDClFGvVD9CWio0bQa0N6r9c89drQOisNlaXXZ_3BzjT8XTlXUoD3J4BKHD89RZ2cL3HT4CO5rIfg_-X_A2iHpEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733370718</pqid></control><display><type>article</type><title>Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Labovsky, V. ; Hofer, E.L. ; Feldman, L. ; Fernández Vallone, V. ; García Rivello, H. ; Bayes-Genis, A. ; Hernando Insúa, A. ; Levin, M.J. ; Chasseing, N.A.</creator><creatorcontrib>Labovsky, V. ; Hofer, E.L. ; Feldman, L. ; Fernández Vallone, V. ; García Rivello, H. ; Bayes-Genis, A. ; Hernando Insúa, A. ; Levin, M.J. ; Chasseing, N.A.</creatorcontrib><description>Bone marrow mesenchymal stromal cells (BM-MSCs) with regenerative potential have been identified in heart. Whether these cells become new cardiac lineage cells by phenomena of transdifferentiation or fusion is also being investigated. Although, these mechanisms give cardiomyocytes, it has to be considered that MSCs transplantation could carry out ossification and calcification processes. An alternative might be the use of myocytes; however, the problem is the arrythmia. For those reasons, is that we investigated how to obtain cardiomyocyte-like cells from human MSCs (hMSCs). The aim of the present work was to evaluate a nuclear reprogramming of the hMSCs by a neonatal rat cardiomyocytes extract (EX) using Streptolysin O (SLO) treatment. hMSCs treated with 57.5
ng/ml SLO presented ball-like, stick-like and myotube-like morphology. In the absence of cardiomyogenic stimuli, hMSCs expressed markers of cardiac phenotype-like sarcomeric α-actinin, connexin-43 and GATA-4. However, when hMSCs were treated with SLO+EX or 10
μM of 5-azacytidine (5-AZA), the expression of these markers were significantly increased and furthermore, expressed SERCA-2, cardiac Troponin I, β-MyHC, desmin, MLC-2a and MLC-2v thus showing the phenotype of mature cardiomyocytes. PCR analysis showed that cardiomyocyte-related genes, such as β1-adrenergic receptor (β1-AR), MLC-2a and cardiac Troponin T, were expressed after SLO+EX treatment like with 5-AZA. We concluded that the extract of neonatal rat cardiomyocytes could promote a nuclear modification of hMSCs to cardiomyogenic-like cells differentiation. Since the 5-AZA treatment appears to be genotoxic and taking into account the obtained results, the nuclear reprogramming by cell extract may be an approach leading to the identification of soluble factors that drives the reprogramming.</description><identifier>ISSN: 0301-4681</identifier><identifier>EISSN: 1432-0436</identifier><identifier>DOI: 10.1016/j.diff.2009.10.001</identifier><identifier>PMID: 19926393</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Animals ; Azacitidine - pharmacology ; Bone Marrow Cells - cytology ; Bone Marrow Cells - metabolism ; Cardiomyogenic differentiation ; Cell Differentiation ; Cell extract and Streptolysin O ; Cell Lineage ; Cells, Cultured ; Child ; Female ; Human mesenchymal stromal cells ; Humans ; Male ; Mesenchymal Stromal Cells - cytology ; Mesenchymal Stromal Cells - metabolism ; Myocytes, Cardiac - cytology ; Myocytes, Cardiac - metabolism ; Rats</subject><ispartof>Differentiation (London), 2010-02, Vol.79 (2), p.93-101</ispartof><rights>2009 International Society of Differentiation</rights><rights>2009 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3</citedby><cites>FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19926393$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Labovsky, V.</creatorcontrib><creatorcontrib>Hofer, E.L.</creatorcontrib><creatorcontrib>Feldman, L.</creatorcontrib><creatorcontrib>Fernández Vallone, V.</creatorcontrib><creatorcontrib>García Rivello, H.</creatorcontrib><creatorcontrib>Bayes-Genis, A.</creatorcontrib><creatorcontrib>Hernando Insúa, A.</creatorcontrib><creatorcontrib>Levin, M.J.</creatorcontrib><creatorcontrib>Chasseing, N.A.</creatorcontrib><title>Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes</title><title>Differentiation (London)</title><addtitle>Differentiation</addtitle><description>Bone marrow mesenchymal stromal cells (BM-MSCs) with regenerative potential have been identified in heart. Whether these cells become new cardiac lineage cells by phenomena of transdifferentiation or fusion is also being investigated. Although, these mechanisms give cardiomyocytes, it has to be considered that MSCs transplantation could carry out ossification and calcification processes. An alternative might be the use of myocytes; however, the problem is the arrythmia. For those reasons, is that we investigated how to obtain cardiomyocyte-like cells from human MSCs (hMSCs). The aim of the present work was to evaluate a nuclear reprogramming of the hMSCs by a neonatal rat cardiomyocytes extract (EX) using Streptolysin O (SLO) treatment. hMSCs treated with 57.5
ng/ml SLO presented ball-like, stick-like and myotube-like morphology. In the absence of cardiomyogenic stimuli, hMSCs expressed markers of cardiac phenotype-like sarcomeric α-actinin, connexin-43 and GATA-4. However, when hMSCs were treated with SLO+EX or 10
μM of 5-azacytidine (5-AZA), the expression of these markers were significantly increased and furthermore, expressed SERCA-2, cardiac Troponin I, β-MyHC, desmin, MLC-2a and MLC-2v thus showing the phenotype of mature cardiomyocytes. PCR analysis showed that cardiomyocyte-related genes, such as β1-adrenergic receptor (β1-AR), MLC-2a and cardiac Troponin T, were expressed after SLO+EX treatment like with 5-AZA. We concluded that the extract of neonatal rat cardiomyocytes could promote a nuclear modification of hMSCs to cardiomyogenic-like cells differentiation. Since the 5-AZA treatment appears to be genotoxic and taking into account the obtained results, the nuclear reprogramming by cell extract may be an approach leading to the identification of soluble factors that drives the reprogramming.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Animals</subject><subject>Azacitidine - pharmacology</subject><subject>Bone Marrow Cells - cytology</subject><subject>Bone Marrow Cells - metabolism</subject><subject>Cardiomyogenic differentiation</subject><subject>Cell Differentiation</subject><subject>Cell extract and Streptolysin O</subject><subject>Cell Lineage</subject><subject>Cells, Cultured</subject><subject>Child</subject><subject>Female</subject><subject>Human mesenchymal stromal cells</subject><subject>Humans</subject><subject>Male</subject><subject>Mesenchymal Stromal Cells - cytology</subject><subject>Mesenchymal Stromal Cells - metabolism</subject><subject>Myocytes, Cardiac - cytology</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Rats</subject><issn>0301-4681</issn><issn>1432-0436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkU2LFDEQhoO4uOPqH_AguXnqsarTne6IFxn8goWFZT2HJF3tZujurEnGdU7-ddPMgDc9BYqnnhTvy9grhC0Cyrf77eDHcVsDqDLYAuATtsFG1BU0Qj5lGxCAVSN7vGTPU9oDQC9rfMYuUalaCiU27PfOxMGH-Ri-0-IdX40UacneZB8WHkZ-f5jNwm1YiM8mxvDIZ0q0uPvjbCbuaJrSO34bJlpht-qM4_QrR-MyH2OY-UJhMbnA0eQTsX7ojpnSC3YxminRy_N7xb59-ni3-1Jd33z-uvtwXblGYK5aMJJwwK4fWrIkB1AOrXWyaaRVxgrT4ShkD21fq9bZfhRIvbHQIgIMVlyxNyfvQww_DpSynn1abzfluEPSXdMqIVQn_k8KITrosC9kfSJdDClFGvVD9CWio0bQa0N6r9c89drQOisNlaXXZ_3BzjT8XTlXUoD3J4BKHD89RZ2cL3HT4CO5rIfg_-X_A2iHpEg</recordid><startdate>20100201</startdate><enddate>20100201</enddate><creator>Labovsky, V.</creator><creator>Hofer, E.L.</creator><creator>Feldman, L.</creator><creator>Fernández Vallone, V.</creator><creator>García Rivello, H.</creator><creator>Bayes-Genis, A.</creator><creator>Hernando Insúa, A.</creator><creator>Levin, M.J.</creator><creator>Chasseing, N.A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20100201</creationdate><title>Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes</title><author>Labovsky, V. ; Hofer, E.L. ; Feldman, L. ; Fernández Vallone, V. ; García Rivello, H. ; Bayes-Genis, A. ; Hernando Insúa, A. ; Levin, M.J. ; Chasseing, N.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Animals</topic><topic>Azacitidine - pharmacology</topic><topic>Bone Marrow Cells - cytology</topic><topic>Bone Marrow Cells - metabolism</topic><topic>Cardiomyogenic differentiation</topic><topic>Cell Differentiation</topic><topic>Cell extract and Streptolysin O</topic><topic>Cell Lineage</topic><topic>Cells, Cultured</topic><topic>Child</topic><topic>Female</topic><topic>Human mesenchymal stromal cells</topic><topic>Humans</topic><topic>Male</topic><topic>Mesenchymal Stromal Cells - cytology</topic><topic>Mesenchymal Stromal Cells - metabolism</topic><topic>Myocytes, Cardiac - cytology</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Labovsky, V.</creatorcontrib><creatorcontrib>Hofer, E.L.</creatorcontrib><creatorcontrib>Feldman, L.</creatorcontrib><creatorcontrib>Fernández Vallone, V.</creatorcontrib><creatorcontrib>García Rivello, H.</creatorcontrib><creatorcontrib>Bayes-Genis, A.</creatorcontrib><creatorcontrib>Hernando Insúa, A.</creatorcontrib><creatorcontrib>Levin, M.J.</creatorcontrib><creatorcontrib>Chasseing, N.A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Differentiation (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Labovsky, V.</au><au>Hofer, E.L.</au><au>Feldman, L.</au><au>Fernández Vallone, V.</au><au>García Rivello, H.</au><au>Bayes-Genis, A.</au><au>Hernando Insúa, A.</au><au>Levin, M.J.</au><au>Chasseing, N.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes</atitle><jtitle>Differentiation (London)</jtitle><addtitle>Differentiation</addtitle><date>2010-02-01</date><risdate>2010</risdate><volume>79</volume><issue>2</issue><spage>93</spage><epage>101</epage><pages>93-101</pages><issn>0301-4681</issn><eissn>1432-0436</eissn><abstract>Bone marrow mesenchymal stromal cells (BM-MSCs) with regenerative potential have been identified in heart. Whether these cells become new cardiac lineage cells by phenomena of transdifferentiation or fusion is also being investigated. Although, these mechanisms give cardiomyocytes, it has to be considered that MSCs transplantation could carry out ossification and calcification processes. An alternative might be the use of myocytes; however, the problem is the arrythmia. For those reasons, is that we investigated how to obtain cardiomyocyte-like cells from human MSCs (hMSCs). The aim of the present work was to evaluate a nuclear reprogramming of the hMSCs by a neonatal rat cardiomyocytes extract (EX) using Streptolysin O (SLO) treatment. hMSCs treated with 57.5
ng/ml SLO presented ball-like, stick-like and myotube-like morphology. In the absence of cardiomyogenic stimuli, hMSCs expressed markers of cardiac phenotype-like sarcomeric α-actinin, connexin-43 and GATA-4. However, when hMSCs were treated with SLO+EX or 10
μM of 5-azacytidine (5-AZA), the expression of these markers were significantly increased and furthermore, expressed SERCA-2, cardiac Troponin I, β-MyHC, desmin, MLC-2a and MLC-2v thus showing the phenotype of mature cardiomyocytes. PCR analysis showed that cardiomyocyte-related genes, such as β1-adrenergic receptor (β1-AR), MLC-2a and cardiac Troponin T, were expressed after SLO+EX treatment like with 5-AZA. We concluded that the extract of neonatal rat cardiomyocytes could promote a nuclear modification of hMSCs to cardiomyogenic-like cells differentiation. Since the 5-AZA treatment appears to be genotoxic and taking into account the obtained results, the nuclear reprogramming by cell extract may be an approach leading to the identification of soluble factors that drives the reprogramming.</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>19926393</pmid><doi>10.1016/j.diff.2009.10.001</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-4681 |
ispartof | Differentiation (London), 2010-02, Vol.79 (2), p.93-101 |
issn | 0301-4681 1432-0436 |
language | eng |
recordid | cdi_proquest_miscellaneous_745933973 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Adolescent Adult Animals Azacitidine - pharmacology Bone Marrow Cells - cytology Bone Marrow Cells - metabolism Cardiomyogenic differentiation Cell Differentiation Cell extract and Streptolysin O Cell Lineage Cells, Cultured Child Female Human mesenchymal stromal cells Humans Male Mesenchymal Stromal Cells - cytology Mesenchymal Stromal Cells - metabolism Myocytes, Cardiac - cytology Myocytes, Cardiac - metabolism Rats |
title | Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T09%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiomyogenic%20differentiation%20of%20human%20bone%20marrow%20mesenchymal%20cells:%20Role%20of%20cardiac%20extract%20from%20neonatal%20rat%20cardiomyocytes&rft.jtitle=Differentiation%20(London)&rft.au=Labovsky,%20V.&rft.date=2010-02-01&rft.volume=79&rft.issue=2&rft.spage=93&rft.epage=101&rft.pages=93-101&rft.issn=0301-4681&rft.eissn=1432-0436&rft_id=info:doi/10.1016/j.diff.2009.10.001&rft_dat=%3Cproquest_cross%3E745933973%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-50a6e1d178d5ebe6d09c1bbc6446b9ab3a71f368058295cb8f31e8ab051100db3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733370718&rft_id=info:pmid/19926393&rfr_iscdi=true |